EDITORIAL BOARD MEMBERS
Department of Biological Science
Sungkyunkwan University
Korea
BIOGRAPHY:
Dr. Cheorl-Ho Kim has been recognized as a pioneer expert in Molecular Hepatology, Glycobiology and Glycomics study, as evidenced and demonstrated by the following confirmations: The Lab has the authors of over 300 peer-reviewed articles published in international scientific journals. His distinguished discoveries recognized in the biomedical area are well documented in the Academic Society from the following outstanding findings: Hepatic B Viral hepatocarcinoma and PTEN (Cancer Research 2003), asialo-1 acid glycoprotein in liver cirrhosis and carcinoma (Hepatology Research, 2003), UDP-N-GlcNAc:β-D-Man-1,4-N-GlcNAc-T-III in hepatitis (Glycoconjugate J, 2003), plasma MMP-9/2 and α-fetoproteins in HBV chronic hepatitis (J. Gastroenterol. and Hepatology. 2004), HBV metastatic potential (FASEB J. 2004), Hepatic V and GnT-III-Apolipoprotein B (JBC. 2004), Disialo GD3 in VSMC responses (JBC. 2004), therapeutic hepatocarcinoma cells (FASEB J. 2004), Transglutaminase 2 signaling in leukemia (FEBS Lett. 2004), bisecting N-GlcNAc-T-III in HBV (J Gastroenterol Hepatol, 2004), Monosialyl GM3 in leukemic differentiation (Glycobiology 2005), MMP-9 in In Vitro Fertilization (British J Obstetrics and Gynecology 2005), disialo GD3 Fas-induced T cells (Glycobiology 2006), GM3 in PTEN-mediated progression (Glycobiology 2006), ROS in sialic GD3-cell function (FASEB J 2006), AP-2a in GM3-PTEN (Glycobiology 2008), sialidase in leukemia (Biochimica et Biophysica Acta 2008), GM3-VEGFR-2 interaction (Glycobiology 2009), GD3 in breast cancer cells (Biological Chemistry 2009), pig CMAH and N-glycolylneuraminic acid (Biochemical J 2010), pST6GalNAc IV for Neu5Acalpha2-3Galbeta1-3GalNAc (Glycoconjugate J 2011), GM3 in TGF-β1-induced EMT (Biochemical J. 2013), VEGFR-2 in neovascularization (J Molecular Medicine 2013), monosialyl GMs and TGF.receptor interaction (Int. J. of Biochem. Cell Biol. 2014), Sialyl Leuis A/X preference of HBx (Molecular Cancer 2014).
Dr. Cheorl-Ho Kim's research interest interest includes Molecular and Cellular Glycobiology, Hepatic viral carcinogenesis, Membrane Glycolipidomics, Sialoglycobiology, Pathogen-Host interaction.
OTHER EDITORIAL BOARD MEMBER
Department of Medicine and Infectious Diseases
Mount Sinai School of Medicine
United States
Department of Pathology, Microbiology and Immunology
School of Medicine
University of South Carolina
United States
Department of Pathology and laboratory Medicine
University of Calgary
Canada
Department of Pathology and Laboratory Medicine
Temple University Hospital
United States
Department of Microbiology & Immunology
Penn State University
United States
Department of Microbiology
King Saud Bin Abdulaziz University for Health Sciences
Saudi Arabia
Department of Global Environmental Health Sciences
Tulane University
United States
STI/HIV/Hepatitis/TB Programs
Arkansas Department of Health
USA
Department of Medical and Surgical Sciences
University of Bologna
Italy
School of Medical & Applied Sciences
Central Queensland University
Australia
Department of Microbial, Biochemical and Food Biotechnology
University of the Free State
South Africa
School of Public Health
The University of Hong Kong
Hong Kong
Department of Virology
The Stephan Angeloff Institute of Microbiology
Bulgaria
Department of Clinical Pathology
Mansoura University
Egypt
Research Department of Physiological Sciences Center for Veterinary Health Sciences
Oklahoma State University
USA
Department of Microbiology
College of Medicine
University of Tikrit
Iraq
Pharmacognosy and Api-Phytotherapy Research Laboratory Mostaganem
University of Algiers
Algeria
